Search results for “Insulin aspart” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 75 patents, we discovered top 24 key players by total patent application. Sanofi SA, Ningbo Kunpeng Biotech Co., Ltd., Novo Nordisk A/S are dominant in this area. They take 45.33% of the total patent filing.
Sanofi SA
France
Patent: 19
Ningbo Kunpeng Biotech Co., Ltd.
China
Patent: 8
Novo Nordisk A/S
Hovedstaden, Denmark
Patent: 7
Beijing Huizhiheng Biotechnology Co Ltd
Beijing Shi, China
Patent: 5
Jilin Huisheng Biological Pharmaceutical Co., Ltd.
Jilin Sheng, China
Patent: 5
Amphastar Nanjing Pharmaceuticals, Inc.
Jiangsu Sheng, China
Patent: 5
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Nanjing Han Xin Pharmaceutical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Corning, Inc.
New York, United States
Patent: 2
HealOr Ltd.
Israel
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 34 patents applied in the last 5 years. We discover 12 most active companies in this area. The fast-growing Ningbo Kunpeng Biotech Co., Ltd., Amphastar Nanjing Pharmaceuticals, Inc., Jilin Huisheng Biological Pharmaceutical Co., Ltd. take 52.94% of patent filing during this period.
Ningbo Kunpeng Biotech Co., Ltd.
China
Patent: 8
Amphastar Nanjing Pharmaceuticals, Inc.
Jiangsu Sheng, China
Patent: 5
Jilin Huisheng Biological Pharmaceutical Co., Ltd.
Jilin Sheng, China
Patent: 5
Beijing Huizhiheng Biotechnology Co Ltd
Beijing Shi, China
Patent: 5
Nanjing Han Xin Pharmaceutical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Sanofi SA
France
Patent: 3
Eli Lilly & Co.
Indiana, United States
Patent: 1
Guangdong Pharmaceutical University
Guangdong Sheng, China
Patent: 1
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Hubei Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 34 patents in last 5 years, we discover 11 new entrants. Ningbo Kunpeng Biotech Co., Ltd., Amphastar Nanjing Pharmaceuticals, Inc., Jilin Huisheng Biological Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Ningbo Kunpeng Biotech Co., Ltd.
China
Patent: 8
Amphastar Nanjing Pharmaceuticals, Inc.
Jiangsu Sheng, China
Patent: 5
Jilin Huisheng Biological Pharmaceutical Co., Ltd.
Jilin Sheng, China
Patent: 5
Beijing Huizhiheng Biotechnology Co Ltd
Beijing Shi, China
Patent: 5
Nanjing Han Xin Pharmaceutical Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Jiangsu Sheng, China
Patent: 3
Eli Lilly & Co.
Indiana, United States
Patent: 1
Guangdong Pharmaceutical University
Guangdong Sheng, China
Patent: 1
YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
Hubei Sheng, China
Patent: 1
Zibo High tech Industrial Development Zone Biomedical Research Institute
undefined undefined
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 5 patents, we discovered top 2 universities and scientific research institutions by total patent application.
Harbin Medical University
Heilongjiang Sheng, China
Patent: 1
Guangdong Pharmaceutical University
Guangdong Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: